United Bank (Georgia)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,423
Closed -$638K 79
2019
Q3
$638K Buy
6,423
+444
+7% +$42.2K 0.47% 62
2019
Q2
$553K Buy
+5,979
New +$568K 0.43% 61
2018
Q4
Sell
-2,944
Closed -$263K 79
2018
Q3
$263K Sell
2,944
-401
-12% -$35.4K 0.21% 72
2018
Q2
$266K Sell
3,345
-815
-20% -$67.7K 0.23% 65
2018
Q1
$371K Sell
4,160
-649
-13% -$62.3K 0.34% 62
2017
Q4
$502K Sell
4,809
-358
-7% -$40.4K 0.43% 57
2017
Q3
$753K Sell
5,167
-90
-2% -$12.3K 0.71% 55
2017
Q2
$683K Buy
5,257
+464
+10% +$56.9K 0.63% 58
2017
Q1
$596K Buy
4,793
+1,267
+36% +$152K 0.57% 59
2016
Q4
$408K Buy
+3,526
New +$393K 0.42% 61

Other funds holding CELG

United Bank (Georgia)'s CELG Position: Q4 2019 in Review

United Bank (Georgia) sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,423 shares — an estimated $638K sold.

United Bank (Georgia) first reported a position in CELG in Q4 2016 and held it in 10 quarters. The position peaked at $753K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • United Bank (Georgia) reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • United Bank (Georgia) sold 6,423 Celgene Corp shares in Q4 2019, an estimated $638K.
  • United Bank (Georgia) first reported a position in Celgene Corp in Q4 2016 and held it in 10 quarters.
  • United Bank (Georgia)'s Celgene Corp position peaked at $753K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on United Bank (Georgia)'s 13F filing for Q4 2019, filed 3 Feb 2020.